Antagonistic Human Fc gamma RIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo

Author(s):
Roghanian, A.; Teige, I.; Martensson, L.; Cox, K.L.; Kovacek, M.; Ljungars, A.; Mattson, J.; Sundberg, A.; Vaughan, A.T.; Shah, V.; Smyth, N.R.; Sheth, B.; Chan, H.T.C.; Li, Z.C.; Williams, E.L.; Manfredi, G.; Oldham, R.J.; Mockridge, C.I.; James, S.A.; Dahal, L.N.; Hussain, K.; Nilsson, B.; Verbeek, J.S.; Juliusson, G.; Hansson, M.; Jerkeman, M.; Johnson, P.W.M.; Davies, A.; Beers, S.A.; Glennie, M.J.; Frendeus, B.; Cragg, M.S.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-04-13
Language
English
Is part of
Cancer Cell (2015), Vol. 27, no. 4, p. 473-488
hdl
1887/100711
doi
10.1016/j.ccell.2015.03.005